<!doctype html>
<html>
<head>
	<meta charset="utf-8">
	<title>final-task</title>
	<link rel="stylesheet" href="stylesheets/style.CSS">
</head>
<body>
	<div class="wrapper">
		<nav>
			<button data-bind="click: turnOnSlide1">Graphics</button>
			<button data-bind="click: turnOnSlide2" class="button2">Calculator</button>
			<button data-bind="click: turnOnSlide3">Competitors</button>
		</nav>
		<section class="slide-graphic" data-bind="visible: firstSlide">
			<h2>Xarelto<sup>®</sup>: An Effective Treatment Option<br/>in Your VTE Patients width Cancer<sup>a,8</sup></h2>
			<p class="signature">%PATIENTS<sup>b</sup></p>
			<div class="graphics" >
				<div class="graduation-wrapper">
					<ul class="graduation">
						<li>8 –</li>
						<li>7 –</li>
						<li>6 –</li>
						<li>5 –</li>
						<li>4 –</li>
						<li>3 –</li>
						<li>2 –</li>
						<li>1 –</li>
						<li>0</li>
					</ul>
				</div>
				<p class="graphics-data">HR 0.69;<br>95% CI 0.36-1.33</p>
				<div class="wrapgraph">
					<div class="firstBlock">
						<p class="graphic-data">7.1<p/>
						<p class="graphic-data">n=20/281</p>
						<p class="graphic-data">ENOHAPARIN /<br/> VKA</p>
					</div>
					<div class="secondBlock">
						<p class="graphic-data">5.1<p/>
						<p class="graphic-data">n=16/316</p>
						<p class="graphic-data">XARELTO</p>
					</div>
					<div class="horizontal-line">
						<hr>
						<p>0</p>
						<p>Cancer</p>
					</div>
				</div>
				<img src="assets/images/people.png" alt="" class="people">
				<div class="minifotter">
					<p><sup>a</sup>Xarelto is contraindicated in lesions or conditions, if they are considered to be a significant risk for major 
					bleeding, which may include the presence of malignant neoplasms at high risk of bleeding.<br>
					<sup>b</sup>Outcome: symptomatic, recurrent VTE.</p>
				</div>
			</div>
		</section>
		<section class="slide-calculator" data-bind="visible: secondSlide">
			<h2>Xarelto<sup>®</sup>Estimator of Resources Saved</h2>
			<div class="firstCalculator">
				<div class="top-calculator">
					<div class="inputSector">
						<input type="text" placeholder="Enter number of DVT patients here" data-bind="value:numperDVT"/>
						<button>CALCULATE</button>
						<button>?</button>
					</div>
					<p class="inputDescription">
						Assumptions to estimate calculations: proportion of patients with DVT contraindicated<br/>for Xarelto or LMWH/VKA<sup>1,2</sup> = 7.5%<br/>Number of patients with DVT – 7.5% = <span class="number" data-bind="text:numberPatients()"> </span> Total number of DVT patients<br/>eligible for dual LMWH/VKA or Xarelto
					</p>
				</div>
				<div class="calculatorBlocks">
					<div class="calculatorResult">
						<p>Injections avoided<sup>3-7</sup></p>
						<input type="text" data-bind="value: injections()"/>
					</div>
					<div>
						<button>+</button>
						<p>Injections avoided = number of LMWH injections received by cancer patients with DVT + LMWH injections received by DVT patients without cancer</p>
					</div>
				</div>
				<div class="calculatorBlocks">
					<div class="calculatorResult">
						<p>INR clinic visits avoided<sup>3,7,8</p>
						<input type="text" data-bind="value: visitsINR()">
					</div>
					<div>
						<button>+</button>
						<p>INR clinic avoided = number of DVT patients eligible for VKA treatment x number of INR monitoring visits per patient</p>
					</div>
				</div>
				<div class="calculatorBlocks">
					<div class="calculatorResult">
						<p>Nurse visits avoided<sup>9</p>
						<input type="text" data-bind="value: visitsNurse()">
					</div>
					<div>
						<button>+</button>
						<p>Nurse assistance visits avoided = number of non-cancer DVT patients eligible for initial LMWH treatment x proportion of these patients treated by nurses in their own homes x mean number of LMWH injections administrated</p>
					</div>
				</div>
				<div class="calculatorBlocks">
					<div class="calculatorResult">
						<p>Hospital bed days saved<sup>10</sup></p>
						<input type="text" data-bind="value: daysSaved()">
					</div>
					<div>
						<button>+</button>
						<p>Hospital bed days saved = number of eligible DVT patients x proportion of DVT patients hospitalised x number of hospital bed days saved per DVT patient treated with Xarelto</p>
					</div>
				</div>
			</div>
			<div class="secondCalculator">
				<div class="top-calculator">
					<div class="inputSector">
						<input type="text" placeholder="Enter number of DVT patients here" data-bind="value: numberPE"/>
						<button>CALCULATE</button>
						<button>?</button>
					</div>
					<p class="inputDescription">
						Assumptions to estimate calculations: proportion of patients with PE contraindicated<br/>for Xarelto or LMWH/VKA<sup>1,2</sup> = 7.5%<br/>Number of patients with PE – 7.5% = <span class="number" data-bind="text:numberPatients2()"> </span> Total number of PE patients<br/>eligible for dual LMWH/VKA or Xarelto
					</p>
				</div>
				<div class="calculatorBlocks">
					<div class="calculatorResult">
						<p>Injections avoided<sup>3-6,11</sup></p>
						<input type="text" placeholder="[B+C]" data-bind="value: injections2()">
					</div>
					<div>
						<button>+</button>
						<p>Injections avoided = number of LMWH injections received by cancer patients with PE + LMWH injections received by PE patients without cancer</p>
					</div>
				</div>
				<div class="calculatorBlocks">
					<div class="calculatorResult">
						<p>INR clinic visits avoided<sup>3,7,8</sup></p>
						<input type="text" placeholder="[I]" data-bind="value: visitsINR2()">
					</div>
					<div>
						<button>+</button>
						<p>INR clinic avoided = number of PE patients eligible for VKA treatment x number of INR monitoring visits per patient</p>
					</div>
				</div>
				<div class="calculatorBlocks">
					<div class="calculatorResult">
						<p>Hospital bed days saved<sup>10</sup></p>
						<input type="text" placeholder="[J]" data-bind="value: daysSaved2()">
					</div>
					<div>
						<button>+</button>
						<p>Hospital bed days saved = number of eligible PE patients x proportion of PE patients hospitalised x number of hospital bed days saved per PE patient treated with Xarelto</p>
					</div>
				</div>
			</div>
			<div class="jointResult">
				<p class="combined">Combined DVT + PE Resources Saved</p>
				<div>
					<p>Injections avoided<sup>3-7,11</p>
					<p data-bind="text: injectons3()"></p>
				</div>
				<div>
					<p>INR clinic visits avoided<sup>3,7,8,11</sup></p>
					<p data-bind="text: visitsINR3()"></p>
				</div>
				<div>
					<p>Nurse visits avoided<sup>9</sup></p>
					<p data-bind="text: visitsNurse3()"></p>
				</div>
				<div>
					<p>Hospital bed days saved<sup>10</sup></p>
					<p data-bind="text: daysSaved3()"></p>
				</div>
			</div>
			<div class="minifotter2">
				<p>Numbers provided are based on general epidemiological research and on clinical trial experience from the Phase III programme with Xarelto. Healthcare practice<br/>may be different in your country (both before and after introduction of Xarelto), and thus the estimation may not reflect your country’s perspective.<br/>Actual costs are not included.</p>
			</div>
		</section>
		<section class="slide-competitors" data-bind="visible: thirdSlide">
			<h2>Xarelto<sup>®</sup>DVT Patients Reported Higher Satisfaction<sup>a,16</sup></h2>
			<div class="wrapper-competitor">
				<div class="preference">
					<p>Higher Preference</p>
					<div class="arrow"></div>
					<p>Lover Preference</p>
				</div>
				<div class="balance">
					<div class="holder"></div>
					<div class="leftScale">
						<p>80.8</p>
					</div>
					<div class="rightScale">
						<p>72.7</p>
					</div>
					<div class="stand">
						<div class="rockethead"></div>
						<div class="rocketbody"></div>
						<div class="pedestal">
							<p>p<0.0001</p>
						</div>
					</div>
					<p class="anagraph">Global satisfaction<sup>b</sup></p>
				</div>
				<div class="legend">
					<div class="clicker1" data-bind="click: downLeft"></div>
					<p class="data-click">Xarelto (N=702)</p>
				</div>
				<div class="legend">
					<div class="clicker2" data-bind="click: downRight"></div>
					<p class="data-click">Enoxaparin/VKA (N=677)</p>
				</div>
			</div>
			<div class="leftBlock">
				<p><span>TSQM II</span><br> Global Satisfaction</p>
			</div>
			<div class="minifotter3">
				<p><sup>a</sup>Patients participating in EINSTEIN DVT trial had confirmed acute symptomatic DVT without symptomatic PE and completed two measures of treatment satisfaction;<br>
                ACTS (Anti Clot Treatment Scale) and TSQM (Treatment Satisfaction Questionnaire for Medication) in follow up visits.<sup>5,16</sup></br>
                <sup>b</sup>Score values given for burdens and benefits measured by ACTS; effectiveness, side effects, convenience and global satisfaction measured by TSQM scale.<sup>16</sup></p>
			</div>
		</section>
	</div>
	<script src="scripts/knockout-3.1.0.js"></script>
	<script src="scripts/script.js"></script>
</body>
</html>